In addition, strategies to increase SOD activity with recombinant SOD molecules and gene transfer led to reduced inflammation and oxidative stress in experimental models of ischemia–reperfusion and contrast-induced AKI [19–21]. This evidence concerns the gene SOD1 and acute kidney injury.